9,590 Shares in ARK Genomic Revolution ETF (BATS:ARKG) Purchased by Sanctuary Advisors LLC

Sanctuary Advisors LLC bought a new stake in shares of ARK Genomic Revolution ETF (BATS:ARKG) in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm bought 9,590 shares of the company’s stock, valued at approximately $222,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in ARKG. Chris Bulman Inc acquired a new position in shares of ARK Genomic Revolution ETF in the second quarter worth $36,000. EverSource Wealth Advisors LLC acquired a new position in ARK Genomic Revolution ETF in the 1st quarter valued at about $49,000. Larson Financial Group LLC lifted its holdings in ARK Genomic Revolution ETF by 4,576.1% in the 2nd quarter. Larson Financial Group LLC now owns 3,320 shares of the company’s stock valued at $78,000 after purchasing an additional 3,249 shares in the last quarter. First Horizon Advisors Inc. lifted its holdings in ARK Genomic Revolution ETF by 9.4% in the 2nd quarter. First Horizon Advisors Inc. now owns 4,650 shares of the company’s stock valued at $109,000 after purchasing an additional 398 shares in the last quarter. Finally, SkyOak Wealth LLC boosted its stake in shares of ARK Genomic Revolution ETF by 14.2% during the 1st quarter. SkyOak Wealth LLC now owns 8,029 shares of the company’s stock worth $231,000 after purchasing an additional 1,000 shares during the last quarter.

ARK Genomic Revolution ETF Stock Up 1.8 %

BATS:ARKG opened at $24.78 on Monday. The firm has a fifty day moving average price of $25.45 and a 200 day moving average price of $25.24.

ARK Genomic Revolution ETF Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.